1. Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
   Aurélie Pelissier et al, 2016, Journal of Ovarian Research CrossRef
2. The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
   Giuseppe Scaletta et al, 2017, Expert Review of Anticancer Therapy CrossRef
3. The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer
   L.-T. Jia et al, 2016, Clinical and Translational Oncology CrossRef
4. Serum levels of human epididymis protein 4 are more stable than cancer antigen 125 in early and mid‐term pregnancy
   Zhiheng Wang et al, 2018, Journal of Obstetrics and Gynaecology Research CrossRef
5. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses
   Xinliang Chen et al, 2015, Clinica Chimica Acta CrossRef
6. Human Epididymis Protein 4 (HE4) mRNA as a Prognostic Marker in Ovarian Tumors in Relation to RMI and CA125
   Manar Yehia et al, 2015, International Journal of Cancer Research CrossRef
7. Evaluation of serum-based cancer biomarkers: A brief review from a clinical and computational viewpoint
   Sohiya Yotsukura et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
8. Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma
   Dong Mi et al, 2016, Journal of Obstetrics and Gynaecology Research CrossRef
9. Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma
   Dong Mi et al, 2020, Archives of Gynecology and Obstetrics CrossRef
10. Tumor markers of breast cancer: New prospectives
    Ahmed M. Kabel, 2017, Journal of Oncological Sciences CrossRef
11. Synthetic Naphthoquinone Derivatives as Anticancer Agents in Ovarian Cancer: Cytotoxicity Assay and Investigation of Possible Biological Mechanisms Action
    Renata Dalmaschio Daltoé et al, 2023, Chemistry & Biodiversity CrossRef
12. A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer
    Melike Bilgi Kamaç et al, 2023, Analytical and Bioanalytical Chemistry CrossRef
13. Assessment of serum angiotensin-converting enzyme in patients with epithelial ovarian cancer
    Fatma Beyazit et al, 2015, Archives of Gynecology and Obstetrics CrossRef
14. Prediction model of adnexal masses with complex ultrasound morphology
    Yuqing Wu et al, 2023, Frontiers in Medicine CrossRef
15. Serum human epididymis protein 4 levels in colorectal cancer patients
    Yasemi̇n Kemal et al, 2017, Molecular and Clinical Oncology CrossRef
16. Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
    Pratistha Koirala et al, 2020, Diagnostics CrossRef
17. The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay
    Jingjing Yang et al, 2013, Clinical Biochemistry CrossRef
18. Diagnostic Value of HE4 in Distinguishing Malignant from Benign Pelvic Masses
    Mesut Onal et al, 2016, Indian Journal of Gynecologic Oncology CrossRef
19. The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction
    Lunshan Wang et al, 2018, International Urology and Nephrology CrossRef